RedHill Biopharma to Present at Bio-Europe Spring 2016 Conference
March 28, 2016 07:00 ET
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel, March 28, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on the development...
Sage Therapeutics to Present Data at the Society of Biological Psychiatry 71st Annual Scientific Meeting
March 28, 2016 07:00 ET
|
SAGE Therapeutics
First time detailed data for SAGE-547 in postpartum depression (PPD) to be presented PPD data includes secondary endpoints and timeline of response SAGE-718 pre-clinical data unveiled in...
Forbes Energy Services Reports 2015 Fourth Quarter and Full Year Financial Results
March 28, 2016 07:00 ET
|
Forbes Energy Services Ltd.
ALICE, Texas, March 28, 2016 (GLOBE NEWSWIRE) -- Forbes Energy Services Ltd. (NASDAQ:FES) today announced financial and operating results for the three months and year ended December 31, 2015. ...
Sunesis Pharmaceuticals Appoints Geoffrey Parker to the Board of Directors
March 28, 2016 07:00 ET
|
Sunesis Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., March 28, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Geoffrey Parker has been appointed to the Sunesis Board of...
Axsome Therapeutics Initiates Phase 3 Study of AXS-02 for Knee Osteoarthritis Associated with Bone Marrow Lesions
March 28, 2016 07:00 ET
|
Axsome Therapeutics, Inc.
First Patient Enrolled in the COAST-1 StudyNon-Opioid, Oral, Targeted, Potentially First-in-Class Mechanism for PainNovel Biomarker-Based Approach for the Treatment of Knee Osteoarthritis...
Alder Reports Phase 2b Trial of ALD403 Meets Primary and Secondary Endpoints Demonstrating Migraine Prevention in Patients with Chronic Migraine
March 28, 2016 07:00 ET
|
Alder BioPharmaceuticals, Inc.
Alder Also Reports Positive Phase 1 Data Supporting Quarterly Single Injection Dosing Strategy for ALD403 Alder to Host Conference Call at 8:30 a.m. Eastern Time Today BOTHELL, Wash., March 28,...
Apricus Reports Top-Line Phase 2b Data for Fispemifene in Symptomatic Secondary Hypogonadism
March 28, 2016 07:00 ET
|
Seelos Therapeutics, Inc.
Fispemifene Failed to Achieve Statistical Significance in Key Clinical Benefit Endpoints Despite Increase in Testosterone Levels Company Will Focus on Internal Pipeline, Including Expanding Market...
Kratos Defense & Rocket Support Services a Key Member of Team Awarded $7.4 Million Contract to Support SSC Pacific Code 551
March 28, 2016 07:00 ET
|
Kratos Defense & Security Solutions, Inc.
SAN DIEGO, March 28, 2016 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its Defense &...
Landmark Infrastructure Partners LP Announces Establishment of Rule 10b5-1 Purchase Program for Executive Officers and Directors
March 28, 2016 07:00 ET
|
Landmark Infrastructure Partners LP
EL SEGUNDO, Calif., March 28, 2016 (GLOBE NEWSWIRE) -- Landmark Infrastructure Partners LP (the “Partnership,” “we,” “us” or “our”) (Nasdaq:LMRK) today announced that its Board of Directors has...
NewStar Named 2015 Lender of the Year by Mergers & Acquisitions
March 28, 2016 07:00 ET
|
NewStar Financial, Inc.
BOSTON, March 28, 2016 (GLOBE NEWSWIRE) -- NewStar Financial Inc. (Nasdaq:NEWS) is pleased to announce that it has been named 2015 Lender of the Year by Mergers & Acquisitions (“M&A”), an...